Hiroe Kayatani

Pulmonary Tumor Thrombotic Microangiopathy Diagnosed Antemortem and Treated with Combination Chemotherapy

Hiroe Kayatani, Kiyoshi Matsuo, Yusuke Ueda et al. · Internal Medicine · 2012 · 64 citations · Full text

Pathology, Pulmonary Hypertension, Lung Biopsy +18

Pembrolizumab-induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in Non-small Cell Lung Cancer

Sachi Okawa, Hiroe Kayatani, Keiichi Fujiwara et al. · Internal Medicine · 2019 · 47 citations · Full text

Immunohematology, Squamous Cell Carcinoma, Immunology +17

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers

Hiromi Watanabe, Eiki Ichihara, Hiroe Kayatani et al. · Cancer Science · 2021 · 47 citations · Full text

MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib

Kiichiro Ninomiya, Kadoaki Ohashi, Go Makimoto et al. · Scientific Reports · 2018 · 45 citations · Full text

Immunology, Pharmacotherapy, Cancer Biology +19

A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)

Kiichiro Ninomiya, Tae Hata, Hiroshige Yoshioka et al. · CHEST Journal · 2019 · 36 citations

Cancer Epidemiology, Medicine, Epidemiology Of Cancer +9